GSDMD and breast cancer: Peng et al. (2020) have revealed that GSDMD gene expression was higher in BC samples than in control samples, and BC patients with CD147 overexpression had a link between GSDMD and a dramatically worse prognosis and overall survival rate, suggesting that GSDMD may act as an unfavorable prognostic marker.